Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-22 18:24 | 2016-12-20 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $119.47 | 12,000 | $1,433,581 | 7,813,110 |
| 2016-12-22 00:50 | 2016-12-19 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $8.69 | 40,000 | $347,656 | 159,084 |
| 2016-12-20 23:57 | 2016-12-19 | RGNP | Sigyn Therapeutics, Inc. | Segelman Joseph | Director, Officer, 10% owner | BUY | $0.10 | 5,000 | $500 | 25,010,000 |
| 2016-12-21 04:24 | 2016-12-16 | ATEC | Alphatec Holdings, Inc. | CROSS LESLIE H | Director | BUY | $4.25 | 15,000 | $63,795 | 65,443 |
| 2016-12-20 00:05 | 2016-12-15 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $8.93 | 40,000 | $357,128 | 199,084 |
| 2016-12-20 02:14 | 2016-12-16 | ATEC | Alphatec Holdings, Inc. | Rich Terry | Director, Officer | BUY | $4.26 | 2,500 | $10,660 | 202,500 |
| 2016-12-20 00:37 | 2016-12-15 | INFU | InfuSystem Holdings, Inc | Steen Eric K | Director, Officer | BUY | $2.33 | 12,000 | $27,937 | 168,296 |
| 2016-12-19 19:31 | 2016-12-15 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $118.72 | 18,000 | $2,136,924 | 7,825,110 |
| 2016-12-17 01:36 | 2016-12-15 | INFU | InfuSystem Holdings, Inc | Meridian OHC Partners, LP | Director, 10% owner | BUY | $2.34 | 200,000 | $467,080 | 2,651,972 |
| 2016-12-17 00:31 | 2016-12-14 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.22 | 100 | $22 | 2,269,932 |
| 2016-12-17 00:56 | 2016-12-15 | OSUR | ORASURE TECHNOLOGIES INC | KUNA MARK L | Officer | OPT+S | $9.30 | 10,000 | $93,000 | 72,965 |
| 2016-12-17 03:20 | 2016-12-14 | DXCM | DEXCOM INC | ROPER JESS | Officer | SELL | $64.14 | 2,442 | $156,619 | 15,797 |
| 2016-12-16 21:50 | 2016-12-15 | BDX | BECTON DICKINSON & CO | Gallagher John E | Officer | SELL | $168.82 | 1,793 | $302,694 | 2,796 |
| 2016-12-16 00:05 | 2016-12-13 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $8.97 | 40,000 | $358,984 | 239,084 |
| 2016-12-15 19:39 | 2016-12-14 | RGNP | Sigyn Therapeutics, Inc. | Segelman Joseph | Director, Officer, 10% owner | BUY | $0.10 | 5,000 | $500 | 25,005,000 |
| 2016-12-14 19:32 | 2016-12-13 | MMM | 3M CO | Roman Michael F | Officer | OPT+S | $180.00 | 4,036 | $726,480 | 5,935 |
| 2016-12-15 00:38 | 2016-12-13 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $117.14 | 12,000 | $1,405,650 | 7,843,110 |
| 2016-12-15 01:00 | 2016-12-12 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | SELL | $40.30 | 5,683 | $229,025 | 49,688 |
| 2016-12-15 05:09 | 2016-12-13 | OSUR | ORASURE TECHNOLOGIES INC | KUNA MARK L | Officer | OPT+S | $9.11 | 17,000 | $154,850 | 72,965 |
| 2016-12-15 05:07 | 2016-12-13 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $9.07 | 71,466 | $647,997 | 731,898 |
| 2016-12-14 00:06 | 2016-12-09 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $9.01 | 15,000 | $135,110 | 279,084 |
| 2016-12-14 01:37 | 2016-12-09 | MMSI | MERIT MEDICAL SYSTEMS INC | Frost Ronald | Officer | OPT+S | $26.25 | 15,000 | $393,750 | 0 |
| 2016-12-13 21:09 | 2016-12-09 | CTSO | Cytosorbents Corp | Chan Phillip P. | Director, Officer | BUY | $5.40 | 4,600 | $24,840 | 448,103 |
| 2016-12-14 00:21 | 2016-12-09 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $64.81 | 10,000 | $648,079 | 72,334 |
| 2016-12-12 23:35 | 2016-12-08 | MMSI | MERIT MEDICAL SYSTEMS INC | STANGER KENT W | Director | SELL | $26.27 | 12,000 | $315,246 | 414,346 |
| 2016-12-13 00:52 | 2016-12-08 | SNOA | Sonoma Pharmaceuticals, Inc. | Miller Robert E | Officer | BUY | $4.86 | 5,000 | $24,300 | 6,714 |
| 2016-12-12 22:57 | 2016-12-09 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $116.97 | 12,000 | $1,403,623 | 7,855,110 |
| 2016-12-13 02:31 | 2016-12-09 | UTMD | UTAH MEDICAL PRODUCTS INC | CORNWELL KEVIN L | Director, Officer | SELL | $69.25 | 3,531 | $244,514 | 241,771 |
| 2016-12-12 16:40 | 2016-12-09 | PODD | INSULET CORP | Alpuche Charles | Officer | BUY | $37.70 | 6,600 | $248,802 | 22,621 |
| 2016-12-12 21:02 | 2016-12-09 | OSUR | ORASURE TECHNOLOGIES INC | KUNA MARK L | Officer | OPT+S | $9.03 | 3,000 | $27,090 | 72,965 |
| 2016-12-10 00:05 | 2016-12-07 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $8.30 | 10,000 | $83,006 | 294,084 |
| 2016-12-10 00:26 | 2016-12-07 | ATRC | AtriCure, Inc. | LUX ANDREW L | Officer | SELL | $18.77 | 5,038 | $94,563 | 49,594 |
| 2016-12-10 01:11 | 2016-12-07 | NEPH | NEPHROS INC | Evans Daron | Director, Officer | BUY | $0.32 | 4,069 | $1,302 | 339,428 |
| 2016-12-09 18:34 | 2016-12-08 | WST | WEST PHARMACEUTICAL SERVICES INC | ZENNER PATRICK J | Director | BUY | $84.53 | 332 | $28,063 | 51,831 |
| 2016-12-08 19:06 | 2016-12-07 | MMM | 3M CO | Hammes Eric D. | Officer | OPT+S | $174.00 | 436 | $75,864 | 1,825 |
| 2016-12-09 02:12 | 2016-12-08 | SNOA | Sonoma Pharmaceuticals, Inc. | Schutz James J | Director, Officer | BUY | $4.88 | 1,000 | $4,880 | 11,040 |
| 2016-12-09 00:14 | 2016-12-07 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $113.22 | 12,000 | $1,358,686 | 7,867,110 |
| 2016-12-09 02:11 | 2016-12-07 | UTMD | UTAH MEDICAL PRODUCTS INC | CORNWELL KEVIN L | Director, Officer | SELL | $70.10 | 5,286 | $370,543 | 245,302 |
| 2016-12-08 23:28 | 2016-12-06 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.25 | 5,000 | $1,250 | 2,269,832 |
| 2016-12-08 00:05 | 2016-12-05 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Officer | SELL | $8.24 | 10,000 | $82,355 | 304,084 |
| 2016-12-08 01:25 | 2016-12-06 | CTSO | Cytosorbents Corp | BLOCH KATHLEEN P. | Officer | BUY | $4.83 | 1,000 | $4,829 | 8,000 |
| 2016-12-07 00:35 | 2016-12-05 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $111.93 | 12,000 | $1,343,132 | 7,879,110 |
| 2016-12-07 00:34 | 2016-12-02 | UFPT | UFP TECHNOLOGIES INC | LATAILLE RONALD J | Officer | SELL | $25.06 | 11,723 | $293,734 | 72,673 |
| 2016-12-07 00:50 | 2016-12-05 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $60.00 | 6,365 | $381,900 | 77,896 |
| 2016-12-07 00:37 | 2016-12-05 | NEPH | NEPHROS INC | Evans Daron | Director, Officer | BUY | $0.34 | 10,620 | $3,611 | 335,359 |
| 2016-12-07 00:49 | 2016-12-05 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $59.83 | 20,000 | $1,196,540 | 352,407 |
| 2016-12-06 21:48 | 2016-12-05 | BDX | BECTON DICKINSON & CO | Sichak Stephen | Officer | SELL | $164.44 | 2,632 | $432,806 | 7,953 |
| 2016-12-06 02:31 | 2016-12-01 | SRTS | Sensus Healthcare, Inc. | Fishman Kalman | Officer | SELL | $6.00 | 187 | $1,122 | 993,463 |
| 2016-12-06 02:28 | 2016-12-01 | SRTS | Sensus Healthcare, Inc. | Cohen Stephen Brad | Officer | SELL | $6.00 | 187 | $1,122 | 993,463 |
| 2016-12-06 02:27 | 2016-12-01 | SRTS | Sensus Healthcare, Inc. | Golin Richard | Officer | SELL | $6.00 | 187 | $1,122 | 993,463 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.